Protein misfolding and aberrant aggregation are associated with many severe disorders, such as neural degenerative diseases, desmin-related myopathy (DRM), and congestive heart failure. Intrasarcoplasmic amyloidosis and increased ubiquitinated proteins are observed in human failing hearts. The pathogenic roles of these derangements in the heart remain unknown. The ubiquitin-proteasome system (UPS) plays a central role in intracellular proteolysis and regulates critical cellular processes. In cultured cells, aberrant aggregation by a mutant (MT) or misfolded protein impairs the UPS. However, this has not been demonstrated in intact animals, and it is unclear how the UPS is impaired. Cross-breeding UPS reporter mice with a transgenic mouse model of DRM featured by aberrant protein aggregation in cardiomyocytes, we found that overexpression of MT-desmin but not normal desmin protein impairs UPS proteolytic function in the heart. The primary defect does not appear to be in the ubiquitination or the proteolytic activity of the 20S proteasome, because ubiquitinated proteins and the peptidase activities of 20S proteasomes were significantly increased rather than decreased in the DRM heart. Therefore, the defect resides apparently in the entry of ubiquitinated proteins into the 20S proteasome. Consistent with this notion, key components (Rpt3 and Rpt5) of 19S proteasomes were markedly decreased, while major components of 20S proteasomes were increased. Additional experiments with HEK cells suggest that proteasomal malfunction observed in MT-desmin hearts is not secondary to cardiac malfunction or to disruption of desmin filaments. Thus, UPS impairment may represent an important pathogenic mechanism underlying cardiac disorders with abnormal protein aggregation.
egradation of most proteins in eukaryotic cells is through the ubiquitin-proteasome system (UPS) (1, 2) . Removing proteins that are either abnormal or no longer needed, the UPS plays critical roles in both quality control and regulation of a number of cellular processes such as cell cycle control, signaling transduction, transcription regulation and gene expression, and apoptosis (3) . For degradation by the UPS, the target protein molecule is first covalently attached by a series of ubiquitin molecules via a process known as ubiquitination. The polyubiquitinated protein is then degraded by the 26S proteasome which consists of a barrelshaped 20S core and the 19S cap on one or both ends of the 20S proteasome. The actual proteolytic activity resides in the interior of the 20S, while the 19S subcomplex plays a critical role in channeling target protein molecules into the 20S proteasomes (1) . Each 20S proteasome complex is composed of two central antiparallel β-rings and two identical α-rings that flank the β-rings. All peptide cleavage activities reside in the interior face of the two β rings of the 20S proteasome (1) . Ubiquitinated proteins accumulate in the cell when the proteolytic function of the proteasomes is inhibited (1) . UPS dysfunction was implicated in the pathogenesis of many neural degenerative diseases such as Alzheimer's, Huntington's, and Parkinson's diseases (4) ; but the pathophysiology of the UPS in cardiac remodeling and failure has rarely been explored (2) .
It is becoming increasingly clear that abnormal protein aggregation is a common process in not only neural degenerative diseases but also myofibrillar myopathies and many cardiac diseases (3, 5) . The presence of aberrant desmin aggregates in the cytoplasm of cardiac and skeletal muscle cells is the hallmark for desmin-related myopathy (DRM), a subcategory of myofibrillar myopathies (6, 7) . DRM often affects both skeletal and cardiac muscle and resultant desminrelated cardiomyopathy (DRC) is the major cause of death in this disease (7) . Notably, abnormal desmin aggregates were very frequently found in human heart failure resulting from ischemic or idiopathic cardiomyopathies (8) . Furthermore, Sanbe et al. recently uncovered that intracellular amyloidosis (i.e., formation of soluble amyloid oligomers from unknown proteins) in cardiac myocytes was highly prevalent in human hearts with hypertrophic or dilated cardiomyopathy (9) . However, it remains unclear how intracellular misfolded and aggregation-prone protein species affect the heart. Data collected from cultured human embryonic kidney (HEK) cells had previously demonstrated impairment of the UPS by aberrant aggregation of a mutant Huntington and a cystic fibrosis membrane conductor protein (5) . UPS malfunction is considered one of the important molecular pathways to neurodegeneration (3, 4, 10) . Using primary culture of neonatal rat cardiac myocytes, Sarikas et al. (11) recently showed that overexpression of some truncated cardiac myosin-binding protein C mutants, major mutations associated with familial hypertrophic cardiomyopathy, led to formation of aberrant protein aggregates and impairment of UPS-mediated proteolysis. However, no in vivo studies have been reported to test the hypothesis that expression of a mutant or misfolded desmin protein can impair the proteolytic function of the UPS in the heart, and it is unclear how a misfolded desmin protein impairs the UPS in the cell.
It has been shown that cardiac-restrictive expression of a human DRM-linked 7-amino-acid (R172 through E178) deletion mutant desmin (MT-des) causes aberrant desmin aggregation, cardiac hypertrophy, and cardiac malfunction in mice, recapitulating human DRC (6) . We report here the first direct in vivo evidence that expression of a human DRM-linked MT-des, a misfolded and aggregation-prone cytoskeletal protein, impairs the proteolytic function of the UPS in transgenic (Tg) mouse hearts. Further analyses reveal that the primary defect is a deficiency in the entry of ubiquitinated proteins into the proteolytic core of the 20S proteasome, and depletion of the 19S proteasomes is likely responsible. Additional experiments with cultured HEK cells further indicate that proteasomal malfunction observed in MT-desmin hearts is not necessarily secondary to cardiac malfunction or to disruption of desmin filaments. It is therefore suggested that UPS impairment may represent an important pathogenic mechanism underlying cardiac disorders with abnormal protein aggregation.
MATERIALS AND METHODS

Tg mice
FVB/N Tg mice ubiquitously expressing a reporter substrate (GFPdgn) for the UPS were recently described (12) . GFPdgn is a green fluorescence protein (GFP) modified by carboxyl fusion of a consensus ubiquitination signal sequence (CL1) isolated from yeast. The abundance of GFPdgn protein in a cell reflects inversely the proteolytic function status of the UPS in the cell. Creation and initial characterization of FVB/N Tg mice with cardiac-specific overexpression of either MT-des or wild-type desmin (WT-des) were previously reported (6) . These mice were used at 9-10 wk of age in the present study unless indicated otherwise. Tg mice were identified by PCR analysis of genomic DNA isolated from tail clips. Institutional guidelines were followed in the care and use of experimental animals.
Clonal HEK cell lines stably expressing a surrogate UPS substrate (GFPu)
GFPu is a modified green fluorescence protein that is similar to GFPdgn (5, 12) . HEK cells (ATCC) were transfected with the GFPu expression plasmid (a generous gift from Dr. Ron Kopito of Stanford University) (5), using liposome-based transfection reagents (Invitrogen). Clonal cell lines stably transfected by the plasmid were selected by their resistance to G418.
Antibodies and reagents
Rabbit polyclonal antibodies (Abs) for ubiquitin and for β-catenin and mouse monoclonal Ab for desmin were from Sigma. Mouse monoclonal Abs for GFP and for Thr41/Ser45 phosphorylated β-catenin and horseradish peroxidase-conjugated goat anti-mouse or rabbit secondary Abs were from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit polyclonal Abs for CryAB were from Stressgen. Lactacystin, rabbit polyclonal Abs for the 19S proteasome components Rpt5 and Rpt3, and for the 20S proteasome subunits, α6 and β2 were from BIOMOL. Polyclonal Ab against the β5 subunit of the 20S proteasome was raised in rabbits (Genemed) using synthetic peptide corresponding to residues 249-262 (DNVADLHDKYSSVS) of the mouse proteasome subunit β5 precursor (pre-β5) sequence. This antibody detects both pre-β5 and the matured β5 subunit.
Protein detection
The protein concentration was determined with BCA reagents (Pierce, Rockford, IL). SDS-PAGE and the Western blot analysis were performed as described previously (12, 13) . ECL-Plus 
Fluorescence microscopy
Cryosections from paraformaldehyde perfusion-fixed mouse hearts were visualized using an Olympus I-70 confocal microscope either directly for GFPdgn distribution or after immunofluorescence labeled for desmin to detect desmin aggregates (6, 12) . To observe the distribution relationship between desmin aggregation and GFPu accumulation, cultured GFPu-2 cells in chamber slides were fixed with 4% paraformaldehyde, immunolabeled for desmin (Alex 565, red), and visualized and imaged for desmin (indirect red fluorescence) and GFPu (direct green fluorescence) with an epi-fluorescence microscope equipped with an IX-71 digital camera (Olympus).
Peptidase assays
The synthetic fluorogenic peptide substrate Suc-LLVY-aminomethycoumarin (AMC, 25 μM, Calbiochem Novabiochem, San Diego, CA), Z-LLE-β naphthylamide (NA, 25 μM) and Bz-VGR-AMC (25 μM) (BIOMOL, Plymouth Meeting, PA) were used for measuring chymotrypsin-like, caspase-like, and trypsin-like activities, respectively, as described previously (12, 13) . Peptide cleavage reactions were carried out in the absence or presence of the proteasome-specific inhibitor MG-132 (20 μM) for chymotrypsin-like and caspase-like activities or epoxomicin (5 μM, Calbiochem) for trypsin-like activity. The portion of activities that was inhibited by respective inhibitors is attributed to the proteasome.
Filter-trap assay for desmin oligomers in the soluble fraction
This was performed according to published protocols with minor modifications (9, 14) . The soluble fraction of myocardial homogenates was boiled in 1X SDS-PAGE sampling buffer for 5 min and then centrifuged at 5,000 × g for 5 min. The supernatant was collected, and its protein concentration was determined as described earlier. The protein extract (5 μg or 10 μg) in a volume of 200 μl from each sample was loaded onto a nitrocellulose filter (pore size of 0.25 μm), using a dot blot apparatus. The membrane was then washed with 300 μl of the same buffer three times on the apparatus. Desmin retained on the membrane was then detected via immunoblotting. The signals were quantitated using the Quantity-One software (Bio-Rad).
Northern blot analysis
Total RNA was isolated from ventricular myocardium using TriReagent (Molecular Research Center, Cincinnati, OH) and used for Northern blot analysis of GFPdgn transcript levels, as described previously (15) . P 32 -labeled GFPdgn cDNA probes was created using the nicktranslation method (15) . Densitometry of the Northern blot signals were performed with phosphoimaging and the Quantity-One software (Bio-Rad).
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Statistical analysis
Results are presented as mean + SD (n=6 mice for each group in all the experiments using mouse ventricular tissue). For cell culture studies, quantitative results were collected from 4 independent repeats. Where applicable, significance levels were calculated using either Student's t test or one-way ANOVA, followed by the Scheffe test. P < 0.05 was considered significant.
RESULTS
Tg expression of MT-des leads to aberrant desmin aggregation in the heart
It has been described previously that moderate overexpression of MT-des but not WT-des specifically in the heart causes formation of aberrant intrasarcoplasmic protein aggregates, disruption of the desmin filament network, and cardiac hypertrophy and malfunction, recapitulating human DRC (6, 16, 17) . Because desmin null mice develop cardiomyopathy (18) , loss-of-function of the desmin filaments likely contributes to cardiac malfunction observed in MT-des Tg hearts. However, an apparent pathological difference between desmin null hearts and DRC hearts is the accumulation of aberrant desmin protein aggregates in the latter. This important pathological difference suggests that additional mechanisms may be involved in the pathogenesis of MT-des induced DRC. The present study tests a hypothesis that the proteolytic function of the UPS is compromised by aberrant desmin aggregation. Both MT-des and WT-des Tg lines have been propagated for a number of generations. To address the question of whether the Tg expression is changed over the propagation, we have reassessed Tg expression of both MT-des and WT-des at the transcript level using RNA dot blot analysis (Fig. 1A, C) . Similar to what was previously reported for these Tg lines, the total steady-state desmin mRNA levels in ventricular myocardium of WT-des Tg and MT-des Tg mice are 16 and 6 times of that of non-Tg (Ntg) littermates, respectively. This is consistent with the findings that the cardiac phenotype of the MT-des mice used in the current study is identical to what was described for the earlier generations of this stable Tg line (data not shown). Despite much lower Tg expression of MT-des relative to WT-des Tg controls, MT-des Tg hearts contain markedly higher soluble oligomeric desmin proteins, compared with WT-des Tg hearts (Fig. 1B, C) and only the MT-des Tg hearts show microscopically apparent aberrant desmin aggregates (Fig. 1D) , indicating that aberrant desmin aggregation occurs only in MT-des Tg hearts.
The UPS is impaired in DRC mouse hearts.
To probe UPS function in MT-des Tg hearts, we measured ubiquitinated proteins in ventricular myocardium. Compared with Ntg littermates, ubiquitinated proteins were significantly increased in both the soluble fractions and the total protein extracts of MT-des Tg hearts but not in WT-des Tg hearts ( Fig. 2A) . Ubiquitinated proteins are normally degraded by the 26S proteasome very efficiently. These findings suggest that the 26S proteasome is likely impaired in MT-des hearts. Consistent with this notion, the protein levels of cytosolic β-catenin (both total and the Thr41/Ser45 phosphorylated forms), a bona fide substrate of the UPS (19) , were also significantly increased (Fig. 2B, C) .
To test whether the proteolytic function of the UPS is indeed impaired in the MT-des Tg hearts, we then cross-bred MT-des Tg or WT-des Tg mice with the GFPdgn Tg mice. GFPdgn protein, a surrogate substrate of the UPS, was markedly increased in MT-des/GFPdgn double Tg hearts, compared with either WT-des/GFPdgn double Tg or GFPdgn single Tg hearts of littermates (Fig.  3A) . Consistently, direct fluorescence confocal microscopic examinations of myocardial sections showed increased green fluorescence intensities in the cardiomyocytes of MT-des/GFPdgn double Tg hearts (Fig. 3C ). This increase in GFPdgn protein in the MT-des/GFPdgn double Tg hearts is due to slower degradation rather than increased synthesis because the steady-state GFPdgn transcript level in MT-des/ GFPdgn double Tg hearts was not different from that in GFPdgn single Tg hearts (Fig. 3B) . These data clearly prove that the proteolytic function of the UPS in the heart is significantly compromised by expression of the MT-des protein.
The impairment is primarily due to diminished entry of ubiquitinated proteins into the 20S proteasome
Theoretically, defects in either ubiquitination or the 26S proteasomes can impair UPS-mediated proteolysis. The abundance of ubiquitin remained unchanged; and more importantly, the ubiquitinated proteins in both the soluble and the insoluble fractions of MT-des Tg hearts were significantly greater than in the WT-des Tg or Ntg hearts ( Fig. 2A) . These indicate that the UPS malfunction is unlikely caused by a deficiency in ubiquitination. Therefore, the primary impairment resides in the 26S proteasome, which is composed of the 19S and the 20S proteasomes. The 19S proteasome recognizes, binds, deubiquitinates, and unfolds polyubiquitinated proteins and feeds the unfolded protein into the 20S proteasome (1). The target protein is then cleaved in the chamber of the 20S proteasome. Therefore, defects in either the 19S or the 20S proteasomes can affect the function of the 26S proteasomes. The function of 20S proteasomes further depends upon the activity of its peptidase subunits: β5, β2, and β1 subunits, which are responsible for chymotrypsin-like, trypsin-like, and caspase-like activities, respectively (1). Using synthetic fluorogenic substrates, we examined proteasomal peptidase activities in the heart. The results show that the activities of all the three peptidase subunits were not decreased in MT-des Tg hearts. On the contrary, all of the three peptidase activities were significantly increased in the MT-des Tg hearts, compared with both Ntg and WT-des Tg hearts (Fig. 4) . Consistently, the protein abundance of components of the 20S proteasomes such as α6, β5 precursor and β2 subunit were significantly increased in the MT-des Tg hearts (Fig. 5) . These findings strongly suggest that the primary defect is not in the proteolytic core of 20S proteasomes but rather in the entry of ubiquitinated proteins into the 20S proteasomes. Impairments of the 19S proteasome, the α-rings of the 20S complex, or both are formerly possible causes. Our further examination showed that key 19S proteasome components such as Rpt3 and Rpt5, were significantly down-regulated in the MT-des expressing hearts but not in the WT-des overexpressing hearts (Fig. 5) , suggesting that depletion of the 19S proteasomes is at least partially responsible for the proteasomal malfunction caused by MT-des.
MT-des impairs UPS in cultured nonmuscle cells
Expression of MT-des can directly compromise the desmin filament network that is unique to myocytes (6, 16) . To rule out the possibility that impairment of the UPS by MT-des relies on disruption of the desmin filament network, we further tested the effect of MT-des on the UPS in HEK cells, which do not normally express desmin. Multiple clonal cell lines that stably express GFPu (a surrogate protein substrate for the UPS) were created as previously reported and designated as GFPu-2 cells (5). As expected, GFPu protein levels in GFPu-2 cells were
Page 6 of 18 (page number not for citation purposes)
significantly increased, and the cells became fluorescent upon proteasomal inhibition (Fig. 6A,  B) . Upon proteasomal inhibition, the total protein level of β-catenin (CTNNB) was also appreciably, but to a much less extent, increased in the HEK cells (Fig. 6A) . Transient transfection of MT-des but not WT-des led to formation of aberrant desmin aggregates (Fig. 6C ) and significantly increased GFPu protein levels in the GFPu-2 cells as evidenced by both Western blot and fluorescence microscopic analyses (Fig. 6C-E) , indicating that UPS impairment by MT-des can occur in a cell type that does not normally express desmin. This demonstrates that MT-des impairing the UPS is not necessarily through disrupting the desmin filaments and that proteasomal malfunction observed in MT-des Tg hearts is not necessarily secondary to cardiac malfunction.
Notably, transient expression of WT-des or MT-des in HEK cells did not significantly alter the chymotrypsin-like, trypsin-like, and caspase-like peptidase activities of the 20S proteasome (data not shown), which is largely consistent with our in vivo findings that suggest that UPS impairment by aberrant desmin aggregation is not through inhibiting the 20S proteasome. The increases in proteasomal peptidase activities observed in MT-des Tg hearts were not detected in the transient transfection experiments with HEK cells, suggesting that the increased peptidase activities in MT-des Tg hearts are likely a compensatory response to chronic proteasomal inhibition.
DISCUSSION
Protein misfolding due to genetic mutations, defects in protein folding machineries, or malfunction of molecular chaperones and/or of the UPS, can cause accumulation of misfolded proteins in the cell and lead to diseases characterized by the presence of abnormal protein aggregates (3, 7) . The molecular pathogenesis of these diseases remains undefined. Although protein folding disorders have been very intensively investigated in the neural system (4), few studies have been reported to explore the pathogenic role(s) of abnormal protein folding and aggregation in the heart. However, emerging data suggest that protein misfolding and aberrant aggregation are very common in disease hearts (8, 9, 20, 21) . DRM caused by mutations in the desmin, the CryAB, or other genes are featured by the presence of desmin-positive aberrant protein aggregates in muscle cells (22, 23) . DRM caused specifically by mutations in the desmin gene is referred to as desminopathy (17) . DRC represents a classic example of protein folding disorders in the heart. Tg mouse models have been created by cardiac-restrictive overexpression of human-DRM-linked mutant desmin or mutant CryAB (6, 15) . Both mouse models of DRC display intrasarcoplasmic desmin aggregates and develop cardiac hypertrophy and cardiac dysfunction, recapitulating the manifestation of human DRC (6, 15, 17) . This study focuses on the DRC mouse model caused by a desmin mutant (6, 16) . We report here multiple lines of evidence that prove for the first time in intact animals that UPS proteolytic function in the heart is severely impaired by expression of a human disease-linked malfolded desmin protein. Further analyses suggest that the primary deficiency resides in the entry of ubiquitinated proteins into the proteolytic core of the 20S proteasomes. Depletion of key components of the 19S proteasomes is likely responsible for the deficiency. Additional experiments in cell culture suggest that aberrant protein aggregation induced by the misfolded desmin plays a major role in the UPS impairment. Hence, proteasomal malfunction may play an important role the pathogenesis of DRM.
The use of a full-length protein reporter to measure UPS function represents a significant advance in UPS-related research (12, 13, 24) . The proteolytic function of the UPS depends on ubiquitination of target protein molecules and proteasome-mediated degradation of the ubiquitinated proteins (1). Factors both internal and external to the UPS in the cell can affect its in vivo function. In vitro proteasomal peptidase activity assays using either crude protein extracts or purified proteasomes can only detect functional changes of a small portion of this complex system, namely the proteolytic core of the 20S proteasome (25) . This is because the small synthetic peptide substrates used in these assays can diffuse freely into the proteolytic chamber of the 20S subcomplex, and their entry into the 20S proteasome is not subject to the regulation of 19S proteasomes. To circumvent this issue, we and others have recently established and validated systems for in situ monitoring dynamic changes of UPS function in cultured cardiomyocytes and in intact mice using a full-length protein substrate (12, 13, 24) . It becomes increasingly clear that using in vitro proteasomal peptidase assays to evaluate the in vivo function of the UPS can be very misleading. This is clearly exemplified by the striking discrepancy between in vivo changes in UPS proteolytic function as reflected by GFPdgn reporter and in vitro peptidase assays, unveiled by the present study. This discrepancy indicates that the primary defect of the proteasomal malfunction in MT-des hearts resides in the entry of ubiquitinated proteins into the 20S proteasome. It has been reported that inhibition of proteasome activity in cultured mammalian cells induces concerted expression of proteasome genes, including components of the 19S and the 20S proteasomes, and de novo formation of the 26S proteasome (26) . Consistently, we have observed significant increases in protein abundance of all of the examined components (α6, β2, and β5 precursor) of the 20S proteasomes in the MT-des heart. However, the key components (Rpt3 and 5) of the 19S proteasome were not increased but significantly decreased. This is in agreement with the deficiency in the entry of ubiquitinated proteins into the 20S proteasome; because 19S proteasomes are responsible for channeling substrates into the 20S. Thus, depletion of the 19S proteasome is likely a major pathogenic step in the proteasomal malfunction observed in DRC hearts.
It should be pointed out that aberrant protein aggregation refers to the entire process by which abnormal protein aggregates, soluble or insoluble, are formed. There is an ongoing debate on whether aberrant protein aggregates are protective or detrimental to the cell (27) (28) (29) . The jury is still out, but it becomes increasingly clear that highly active intermediate species, such as the soluble high molecular weight oligomers of MT-des protein in the present study (Fig. 1B) , can be harmful to the cell (3, 30) . As elucidated by the present study, one of the main mechanisms is causing impairment of UPS proteolytic function.
As in other eukaryotic cells, the UPS plays critical roles in maintaining homeostasis and regulating many cellular processes in cardiac myocytes. Degradation of most sarcomeric proteins such as myosin and troponin (31) , hypertrophic signaling proteins such as calcineurin and β-catenin (19, 32) , and proapoptotic proteins such as activated caspase 3 (33) , is known to depend on the UPS. Conceivably, UPS dysfunction can affect structural integrity, functional dynamics, hypertrophic responses, and even survival of cardiac myocytes. We recently reported that the cardiotoxicity of doxorubicin may be caused by its ability to activate UPS in cardiomyocytes (12) . Because intercellular amyloidosis, a form of aberrant prtoein aggregation, occurs frequently in failing human hearts (9) , it is reasonable to postulate that protein aggregation induced proteasomal malfunction is potentially an important pathogenic process underlying cardiac remodeling and failure (Fig. 7) and warrants further investigations. image of desmin transcript levels in Ntg, WT-des Tg, and MT-des Tg hearts at 9 wk of age. Four micrograms of total RNA isolated from ventricular myocardium were used for each dot. P 32 -labeled probes made from the open reading frame of the desmin cDNA using random priming were used to hybridize desmin transcripts (both endogenous and Tg) on the nitrocellulose membrane and radioactive signals from the bound probes were exposed to a phosphoimaging screen and analyzed by a Personal Molecular Imager (Bio-Rad). Each dot represents an individual mouse. Note that the expression of desmin at the transcriptional level is increased by a factor of 16 in WT-des Tg hearts and by a factor of 6 in MT-des tg hearts, compared with Ntg hearts (C). B) A representative image of the filter-trap assay for oligomeric desmin protein in the soluble fraction of myocardium. Indicated amount soluble proteins were applied to a nitrocellulose membrane (pore size = 0.25 µm). The desmin in SDS-resistant protein complexes that failed to pass through the membrane, was trapped on the membrane and detected and quantitatively analyzed by immunoblots and densitometry. C) A summary of quantitative data from experiments illustrated in (A) and (B). *P < 0.01, compared with Ntg (one-way ANOVA); #P < 0.01, compared with WT-des Tg (t test), (D) Immunofluorescence confocal micrographs of ventricular myocardium from Ntg, WT-des Tg, and MT-des Tg hearts. Cryosections from perfusion-fixed ventricular myocardium were immunofluorescence-labeled for desmin (green). In the Ntg cardiomyocytes, desmin protein distributes in a striated pattern with increased amount at the intercalated disks. The distribution of desmin protein in the WT-des Tg heart follows a pattern identical to that in the Ntg heart ,whereas the normal desmin distribution is remarkably altered, and apparent desmin aggregates (as identified by arrows) are present in the MT-des Tg hearts. Scale bar represents 50 µm. 
